- A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
-
Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, Cho NH, Jeung HC
- KMID: 1522937
- Cancer Res Treat.
- 2007 Sep;39(3):134-137.
Atypical medullary carcinomas and carcinosarcoma have unique histopathological features. Here we present a case with a breast malignancy that had pathological characteristics of both. A 54-year old patient with a... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer
-
Choi IS, Oh DY, Kim BS, Lee KW, Kim JH, Lee JS
- KMID: 1522931
- Cancer Res Treat.
- 2007 Sep;39(3):99-103.
PURPOSE: We investigated the efficacy and safety of a combination of oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) as first-line palliative chemotherapy for elderly patients with metastatic or recurrent gastric... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional Link between DNA Damage Responses and Transcriptional Regulation by ATM in Response to a Histone Deacetylase Inhibitor TSA
-
Lee JS
- KMID: 1522934
- Cancer Res Treat.
- 2007 Sep;39(3):116-124.
PURPOSE: Mutations in the ATM (ataxia-telangiectasia mutated) gene, which encodes a 370 kd protein with a kinase catalytic domain, predisposes people to cancers, and these mutations are also linked to... -
- CITED
-
- Close
- SHARE
-
- Close
- Activation of ATM-dependent DNA Damage Signal Pathway by a Histone Deacetylase Inhibitor, Trichostatin A
-
Lee JS
- KMID: 1522935
- Cancer Res Treat.
- 2007 Sep;39(3):125-130.
PURPOSE: Ataxia-telangiectasia mutated (ATM) kinase regulates diverse cellular DNA damage responses, including genome surveillance, cell growth, and gene expression. While the role of histone acetylation/deacetylation in gene expression is well... -
- CITED
-
- Close
- SHARE
-
- Close
- Extraskeletal Mesenchymal Chondrosarcoma of the Heart Responded to Systemic Chemotherapy: A Case Report
-
Hsing CT, Oh SY, Lee S, Kwon HC, Kim SH, Park TH, Woo JS, Na SH, Kim HJ
- KMID: 1522936
- Cancer Res Treat.
- 2007 Sep;39(3):131-133.
Mesenchymal chondrosarcoma is a rare cartilaginous neoplasm of an extraskeletal origin, and this predominately occurs in the head and neck, and also in the lower extremities. Fewer than twenty cases... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of an Induction Chemotherapy Combination with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer
-
Ahn JS, Cho SH, Kim OK, Lee JK, Yang DH, Kim YK, Lee JJ, Lim SC, Kim HJ, Chung WK, Chung IJ
- KMID: 1522930
- Cancer Res Treat.
- 2007 Sep;39(3):93-98.
PURPOSE: This study was performed to determine the feasibility and safety of the use of induction chemotherapy combined with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by concurrent chemoradiation therapy for... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose Transporter-1 Expression in Squamous Cell Carcinoma of the Tongue
-
Choi YS, Kim SJ, Kim DS, Park SJ, Park Y, Shin HJ, Jung KY, Baek SK, Shin BK, Choi JW, Kim BS, Shin SW, Kim YH, Kim JS
- KMID: 1522933
- Cancer Res Treat.
- 2007 Sep;39(3):109-115.
PURPOSE: Tumor cells are known to express hypoxia-related proteins such as glucose transporter-1 (Glut-1). These hypoxia-induced changes may allow tumor cells to survive under sustained hypoxic microenvironments, and the surviving... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone Metastasis from Primary Hepatocellular Carcinoma: Characteristics of Soft Tissue Formation
-
Kim S, Chun M, Wang H, Cho S, Oh YT, Kang SH, Yang J
- KMID: 1522932
- Cancer Res Treat.
- 2007 Sep;39(3):104-108.
PURPOSE: To assess the characteristics of bone metastasis from hepatocellular carcinoma and the radiation field arrangement based on imaging studies. MATERIALS AND METHODS: Fifty-three patients (84 lesions) with bone metastasis from... -
- CITED
-
- Close
- SHARE
-
- Close
